Arindam Kolay

Mr. Arindam Kolay


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2026 in Current Diabetes Reviews
Verified
Journal Article
Open access
PDF file
AKArindam Kolay
Arindam Kolay
RSRavindra Pal Singh
Ravindra Pal Singh
SSSwetaleena Shaw
Swetaleena Shaw
AKAman Kumar
Aman Kumar
SKSourabh Kosey
Sourabh Kosey
SSShivam Singh
Shivam Singh
Recent advancements in drug delivery technologies, bioactive molecules, and biomaterial design have transformed the therapeutic landscape of diabetic wound management. Diabetic wounds remain a major clinical challenge due to persistent inflammation, impaired angiogenesis, and reduced tissue regeneration, primarily caused by chronic hyperglycemia and oxidative stress. Emerging nanotechnology-based systems, such as polymeric, metallic, and lipid nanoparticles, enable site-specific drug delivery with enhanced stability, biocompatibility, and sustained release, thereby improving therapeutic efficacy. Complementary nanocarrier platforms like liposomes, niosomes, hydrogels, and nanohydrogels provide a moist microenvironment essential for cell proliferation and tissue remodeling while ensuring controlled drug release for faster wound closure. Advanced strategies, including dendrimers, transferosomes, microneedle arrays, and 3D-printed scaffolds, offer personalized, minimally invasive, and adaptive therapeutic solutions. Nanoemulsions and nanocapsules facilitate effective encapsulation and transport of hydrophobic drugs, broadening their clinical applicability. Incorporating bioactive growth factors such as VEGF, PDGF, chemokines, and stem cell-derived exosomes into these systems further enhances angiogenesis, modulates inflammation, and accelerates granulation tissue formation. Meanwhile, biopolymers like collagen, chitosan, hyaluronic acid, and silk sericin serve as natural scaffolds that support cell adhesion, migration, and epithelialization. Collectively, these emerging technologies signify a paradigm shift toward integrated, patient-specific, and regenerative approaches for diabetic wound healing, addressing the limitations of conventional therapies through the synergy of nanotechnology and bioengineering.

12 August 2025
Verified
Book Chapter
Open access
PDF file
AKArindam Kolay
Arindam Kolay
RSRavindra Pal Singh
Ravindra Pal Singh
RTRewak Tyagi
Rewak Tyagi
PRPrashant Regar
Prashant Regar
SSShivam Singh
Shivam Singh
Diabetic wounds, a severe consequence among diabetic patients, significantly contribute to disability and mortality. A significant part of this work on the pathophysiology of diabetic wound healing has mostly focused on processes driven by chronic inflammation, hyperglycaemia and dysfunctions in microcirculation. As per the recent research, defensins could have an important part in the initiation and maintenance of diabetic wound healing. Chronic, non-healing process, particularly in the lower limbs, are the result of diabetes's obstruction of various stages of the wound healing. Diabetes-related hyperglycemia disrupts the regular operation of vital cells such fibroblasts, keratinocytes and endothelial cells that participate in the healing of serious wounds. Mononeuropathy, commonly seen in diabetic individuals, impairs diabetic wound healing by reducing pain sensitivity, making injuries go unnoticed and worsening progressively. Diabetic wounds are also more risk of infection due to a weakened immune response, further delaying healing and increasing the risk of severe complications like amputation or gangrene. Recent study into the molecular and cellular processes of diabetic wound healing has led to the development of new treatment approaches, including stem cell therapy, growth factors and bioengineered skin substitutes to promote tissue regeneration. In addition, advanced treatments like nanotechnology and gene therapy offer targeted interventions for better healing outcomes. Managing diabetic wounds functionally requires a comprehensive strategy involving glucose control, infection management, and modern wound care practices. Ongoing study is very crucial for discovering innovative therapies that improve the standard of care and patient outcomes in diabetes.